- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04896333
Acceptability in Dialogues With the Robot EBO
Acceptability in Dialogues Between the Robot EBO and Older Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Cáceres, Spain, 10003
- University of Extremadura
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Users of socio-health centers in Extremadura (Spain).
- Patients with neurological pathology diagnosed by a specialist doctor.
- Over 65 years of age
- Minimental State Examination with a score greater than or equal to 21 (mild-moderate cognitive impairment).
Exclusion Criteria:
- Severe cognitive impairment
- Language impairment that prevents the use of verbal communication.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Robot interaction
EBO is a robotic platform consisting of the following: A screen display capable of generating emotions (sadness, joy, neutral, anger, disgust and surprise), RGB camera, basic navigation system. EBO must be controlled by a teleoperator through a user-friendly and simple interface. Communication should be as immediate as possible, as well as predefined. In any case, the dialogue flow can be modified if necessary. The interface, at the same time, allows the possibility of sending emotions and small movements to the robot, to accompany the dialogue with certain elements of emotionality. The experiment replicates the Wizard of Oz technique. In this technique, the human tele-operator controls the robot without the person noticing it as he is in another room. For this purpose, a user interface will be displayed on the teleoperator's terminal and the commands will be reproduced by the EBO robot |
The participants will interact with the Robot EBO.
The robot will be control by an operator that will conduct a dialogue.
The dialogue will include questions related to the social, leisure, activities of daily living and informative areas.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Robot-user interaction during the conversation: Conversation topic that most motivates the user or with which the user most interacts with the robot measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Robot-user interaction during the conversation measured by recording and viewing the conversation
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Robot-user interaction during the conversation: attempts to touch the robot by the patient measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Robot-user interaction during the conversation measured by recording and viewing the conversation
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Robot-user interaction during the conversation: times the user asks the robot questions measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Robot-user interaction during the conversation measured by recording and viewing the conversation.
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Robot-user interaction during the conversation: emotions that the conversation provokes in the patient measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Robot-user interaction during the conversation measured by recording and viewing the conversation: emotions that the conversation provokes in the user (Standard, happy, sad, angry)
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Robot-user interaction during the conversation: number of total interactions measured by recording and viewing the conversation
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Robot-user interaction during the conversation measured by recording and viewing the conversation.
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Conversation parameters: time of the dialogue measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Conversation parameters measured by the robot's register
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Conversation parameters: speed of response measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Conversation parameters (measured by the robot's register): speed of response (time taken by the patient to respond)
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Conversation parameters: eye contact and patient's attention measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Conversation parameters (measured by the robot's register): eye contact with the robot and the attention of the patient to follow the conversation.
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
Conversation parameters: repetition of questions measured by the robot's register
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Conversation parameters (measured by the robot's register): number of times the patient needed to be asked a question again.
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
User acceptability of the robot with the Technology Acceptance Model questionnaire
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
User acceptability of the robot measured with the Technology Acceptance Model. This scale has good validity and reliability, with a Cronbach's alpha value above 0.8 (Alenazy, Mugahed Al-Rahmi, & Khan, 2019). It assesses the following dimensions relating to the technology product:
A higher scores indicates a higher acceptability. |
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
|
User acceptability of the robot measures with an specific designed questionnaire
Time Frame: Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
User acceptability of the robot measured with a questionnaire designed by the authors of the study.
The questionnaire has 10 items that evaluate the acceptability of the robot by the user.
This 10 questions have 3 choice answer with the options being yes, no, I don not know.
There is one open question to collect qualitative data a¡regarding the dialogue and the acceptability.
|
Measured at the exposure/dialogue of the patient with the robot EBO during the intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 128/2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nervous System Diseases
-
Bracco Diagnostics, IncCompletedCentral Nervous System Neoplasms | Central Nervous System Disease
-
Delve Bio, Inc.Not yet recruiting
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
Bracco Diagnostics, IncCompletedCentral Nervous System Diseases | Central Nervous System NeoplasmsUnited States
-
University of MichiganCompletedAutonomic Peripheral Nervous System DiseasesUnited States
-
UNC Lineberger Comprehensive Cancer CenterRecruitingCentral Nervous System TumorUnited States
-
Washington University School of MedicineRecruitingCentral Nervous SystemUnited States
-
The Hong Kong Polytechnic UniversityUnknownAutonomic Nervous System DisorderChina
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
National Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
Clinical Trials on Interaction and exposure with the Robot EBO
-
University Hospital, ToulouseCentre National de la Recherche Scientifique, FranceCompletedCochlear ImplantationFrance
-
Assistance Publique - Hôpitaux de ParisUniversità degli Studi di Trento; Czech Technical University in Prague; Institut... and other collaboratorsCompletedPatient Participation | Professional Role | Patient Relations, NurseFrance
-
SimpleC, LLCUniversity of Georgia; Advanced Medical ElectronicsCompletedQuality of Life | Cognitive Impairment | Dementia | Aging | Mild Cognitive Impairment | Engagement, Patient | MoodUnited States
-
University Hospital, GrenobleIntuitive Surgical; Clinical Investigation Centre for Innovative Technology...Unknown
-
University Hospital, Strasbourg, FranceTerminatedKeratitis | Pterygium | Corneal Perforation | Corneal Opacity Corneal ThinningFrance
-
University Hospital of Mont-GodinneUniversité Catholique de LouvainRecruiting
-
University Hospital of Mont-GodinneUniversité Catholique de Louvain; Fonds National de la Recherche Scientifique; Louvain Bionics, UCLouvainActive, not recruitingChronic Cerebellar Stroke | Healthy Individuals (Controls)Belgium
-
Peking University Third HospitalBeihang UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot Foundation; URC Necker Cochin, FranceCompletedModerate to Severe DementiaFrance
-
Centre Hospitalier Universitaire de la RéunionNot yet recruitingSun ExposureMayotte, Réunion